Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.

Cassis P, Locatelli M, Corna D, Villa S, Rottoli D, Cerullo D, Abbate M, Remuzzi G, Benigni A, Zoja C.

Kidney Int. 2019 May 10. pii: S0085-2538(19)30486-7. doi: 10.1016/j.kint.2019.04.024. [Epub ahead of print]

PMID:
31307778
2.

Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.

Rota C, Morigi M, Cerullo D, Introna M, Colpani O, Corna D, Capelli C, Rabelink TJ, Leuning DG, Rottoli D, Benigni A, Zoja C, Remuzzi G.

Stem Cell Res Ther. 2018 Aug 14;9(1):220. doi: 10.1186/s13287-018-0960-8.

3.

Fenofibrate attenuates cardiac and renal alterations in young salt-loaded spontaneously hypertensive stroke-prone rats through mitochondrial protection.

Castiglioni L, Pignieri A, Fiaschè M, Giudici M, Crestani M, Mitro N, Abbate M, Zoja C, Rottoli D, Foray C, Fiordaliso F, Guerrini U, Tremoli E, Sironi L, Gelosa P.

J Hypertens. 2018 May;36(5):1129-1146. doi: 10.1097/HJH.0000000000001651.

PMID:
29278547
4.

Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function.

Perico L, Morigi M, Rota C, Breno M, Mele C, Noris M, Introna M, Capelli C, Longaretti L, Rottoli D, Conti S, Corna D, Remuzzi G, Benigni A.

Nat Commun. 2017 Oct 17;8(1):983. doi: 10.1038/s41467-017-00937-2.

5.

The Role of Angiotensin II in Parietal Epithelial Cell Proliferation and Crescent Formation in Glomerular Diseases.

Rizzo P, Novelli R, Rota C, Gagliardini E, Ruggiero B, Rottoli D, Benigni A, Remuzzi G.

Am J Pathol. 2017 Nov;187(11):2441-2450. doi: 10.1016/j.ajpath.2017.07.004. Epub 2017 Aug 12.

PMID:
28807596
6.

MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.

Zanchi C, Macconi D, Trionfini P, Tomasoni S, Rottoli D, Locatelli M, Rudnicki M, Vandesompele J, Mestdagh P, Remuzzi G, Benigni A, Zoja C.

Diabetologia. 2017 Jun;60(6):1114-1125. doi: 10.1007/s00125-017-4248-9. Epub 2017 Mar 31.

7.

Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy.

Zoja C, Locatelli M, Corna D, Villa S, Rottoli D, Nava V, Verde R, Piscitelli F, Di Marzo V, Fingerle J, Adam JM, Rothenhaeusler B, Ottaviani G, BĂ©nardeau A, Abbate M, Remuzzi G, Benigni A.

Nephron. 2016;132(1):59-69. doi: 10.1159/000442679. Epub 2015 Dec 9.

PMID:
26646377
8.

Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease.

Buelli S, Perico L, Galbusera M, Abbate M, Morigi M, Novelli R, Gagliardini E, Tentori C, Rottoli D, Sabadini E, Saito T, Kawano M, Saeki T, Zoja C, Remuzzi G, Benigni A.

EBioMedicine. 2015 Mar 6;2(5):456-66. doi: 10.1016/j.ebiom.2015.03.003. eCollection 2015 May.

9.

Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury.

Morigi M, Perico L, Rota C, Longaretti L, Conti S, Rottoli D, Novelli R, Remuzzi G, Benigni A.

J Clin Invest. 2015 Feb;125(2):715-26. doi: 10.1172/JCI77632. Epub 2015 Jan 20.

10.

Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney disease.

Zoja C, Corna D, Locatelli M, Rottoli D, Pezzotta A, Morigi M, Zanchi C, Buelli S, Guglielmotti A, Perico N, Remuzzi A, Remuzzi G.

Nephron. 2015;129(1):52-61. doi: 10.1159/000369149. Epub 2014 Dec 17.

11.

Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.

Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, Remuzzi G, Zoja C, Morigi M.

J Am Soc Nephrol. 2014 Aug;25(8):1786-98. doi: 10.1681/ASN.2013050450. Epub 2014 Feb 27.

12.

Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitor.

Zanchi C, Locatelli M, Benigni A, Corna D, Tomasoni S, Rottoli D, Gaspari F, Remuzzi G, Zoja C.

PLoS One. 2013 Aug 14;8(8):e70775. doi: 10.1371/journal.pone.0070775. eCollection 2013.

13.

Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes.

Zoja C, Cattaneo S, Fiordaliso F, Lionetti V, Zambelli V, Salio M, Corna D, Pagani C, Rottoli D, Bisighini C, Remuzzi G, Benigni A.

Am J Physiol Renal Physiol. 2011 Nov;301(5):F1114-23. doi: 10.1152/ajprenal.00122.2011. Epub 2011 Aug 3.

14.

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.

Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C.

J Immunol. 2011 Jul 1;187(1):172-80. doi: 10.4049/jimmunol.1100491. Epub 2011 Jun 3.

15.

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.

Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A.

Am J Physiol Renal Physiol. 2009 Nov;297(5):F1448-56. doi: 10.1152/ajprenal.00340.2009. Epub 2009 Aug 12.

16.

V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.

Perico N, Zoja C, Corna D, Rottoli D, Gaspari F, Haskell L, Remuzzi G.

Kidney Int. 2009 Nov;76(9):960-7. doi: 10.1038/ki.2009.267. Epub 2009 Jul 22.

17.

Disruption of the Ang II type 1 receptor promotes longevity in mice.

Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G.

J Clin Invest. 2009 Mar;119(3):524-30. doi: 10.1172/JCI36703. Epub 2009 Feb 9.

18.

Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.

Zanchi C, Zoja C, Morigi M, Valsecchi F, Liu XY, Rottoli D, Locatelli M, Buelli S, Pezzotta A, Mapelli P, Geelen J, Remuzzi G, Hawiger J.

J Immunol. 2008 Jul 15;181(2):1460-9.

19.

Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.

Morigi M, Introna M, Imberti B, Corna D, Abbate M, Rota C, Rottoli D, Benigni A, Perico N, Zoja C, Rambaldi A, Remuzzi A, Remuzzi G.

Stem Cells. 2008 Aug;26(8):2075-82. doi: 10.1634/stemcells.2007-0795. Epub 2008 May 22.

20.

Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury.

Abbate M, Zoja C, Corna D, Rottoli D, Zanchi C, Azzollini N, Tomasoni S, Berlingeri S, Noris M, Morigi M, Remuzzi G.

J Am Soc Nephrol. 2008 Jun;19(6):1158-67. doi: 10.1681/ASN.2007060686. Epub 2008 Mar 19.

21.

Insulin-like growth factor-1 sustains stem cell mediated renal repair.

Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, Abbate M, Zoja C, Remuzzi G.

J Am Soc Nephrol. 2007 Nov;18(11):2921-8. Epub 2007 Oct 17.

22.

Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.

Zoja C, Casiraghi F, Conti S, Corna D, Rottoli D, Cavinato RA, Remuzzi G, Benigni A.

Arthritis Rheum. 2007 May;56(5):1629-37.

23.

Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.

Gianella A, Nobili E, Abbate M, Zoja C, Gelosa P, Mussoni L, Bellosta S, Canavesi M, Rottoli D, Guerrini U, Brioschi M, Banfi C, Tremoli E, Remuzzi G, Sironi L.

Am J Pathol. 2007 Apr;170(4):1165-77.

24.

Beneficial effect of TGFbeta antagonism in treating diabetic nephropathy depends on when treatment is started.

Benigni A, Zoja C, Campana M, Corna D, Sangalli F, Rottoli D, Gagliardini E, Conti S, Ledbetter S, Remuzzi G.

Nephron Exp Nephrol. 2006;104(4):e158-68. Epub 2006 Aug 10.

PMID:
16902320
25.

Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease.

Zoja C, Corna D, Rottoli D, Zanchi C, Abbate M, Remuzzi G.

Kidney Int. 2006 Jul;70(1):97-103. Epub 2006 May 10.

26.

Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone.

Benigni A, Zoja C, Tomasoni S, Campana M, Corna D, Zanchi C, Gagliardini E, Garofano E, Rottoli D, Ito T, Remuzzi G.

J Am Soc Nephrol. 2006 Jun;17(6):1624-32. Epub 2006 May 10.

27.

Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.

Benigni A, Zoja C, Zatelli C, Corna D, Longaretti L, Rottoli D, Maggioni P, Todeschini M, Noris M, Remuzzi G.

Kidney Int. 2004 Nov;66(5):1959-65.

28.

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure.

Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G.

J Am Soc Nephrol. 2004 Jul;15(7):1794-804.

29.

Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways.

Donadelli R, Zanchi C, Morigi M, Buelli S, Batani C, Tomasoni S, Corna D, Rottoli D, Benigni A, Abbate M, Remuzzi G, Zoja C.

J Am Soc Nephrol. 2003 Oct;14(10):2436-46.

30.

Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.

Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, Gagliardini E, Rottoli D, Zanchi C, Abbate M, Ledbetter S, Remuzzi G.

J Am Soc Nephrol. 2003 Jul;14(7):1816-24.

31.

Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Abbate M, Zoja C, Morigi M, Rottoli D, Angioletti S, Tomasoni S, Zanchi C, Longaretti L, Donadelli R, Remuzzi G.

Am J Pathol. 2002 Dec;161(6):2179-93.

32.

How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.

Zoja C, Corna D, Camozzi D, Cattaneo D, Rottoli D, Batani C, Zanchi C, Abbate M, Remuzzi G.

J Am Soc Nephrol. 2002 Dec;13(12):2898-908.

33.

Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts.

Abbate M, Zoja C, Rottoli D, Corna D, Tomasoni S, Remuzzi G.

Kidney Int. 2002 Jun;61(6):2066-77. Erratum in: Kidney Int 2002 Aug;62(2):731.

34.

Effect of combining ACE inhibitor and statin in severe experimental nephropathy.

Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G.

Kidney Int. 2002 May;61(5):1635-45.

35.

Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.

Zoja C, Benigni A, Noris M, Corna D, Casiraghi F, Pagnoncelli M, Rottoli D, Abbate M, Remuzzi G.

Kidney Int. 2001 Aug;60(2):653-63.

36.

Supplemental Content

Loading ...
Support Center